User profiles for Geert Byttebier
Geert ByttebierVerified email at skynet.be Cited by 2200 |
Antihypertensive treatment based on conventional or ambulatory blood pressure measurement: a randomized controlled trial
Context. —Ambulatory blood pressure (ABP) monitoring is used increasingly in clinical practice,
but how it affects treatment of blood pressure has not been determined. Objective. —To …
but how it affects treatment of blood pressure has not been determined. Objective. —To …
Postoperative residual paralysis in outpatients versus inpatients
…, J De Witte, J De Veylder, G Byttebier… - Anesthesia & …, 2006 - journals.lww.com
IMPLICATIONS: When administering neuromuscular blocking drugs, anesthesiologists in
this study used clinical tests or pharmacological reversal, but seldom neuromuscular …
this study used clinical tests or pharmacological reversal, but seldom neuromuscular …
The effects of ARBs, ACEis, and statins on clinical outcomes of COVID-19 infection among nursing home residents
… Teo MD, PhD e , Geert Byttebier MSc f , Guy De Tré PhD d , Luc Belmans MD g , Richard
Dobson PhD h , Evelien Wynendaele PharmD, PhD a , Christophe Van De Wiele MD, PhD i , …
Dobson PhD h , Evelien Wynendaele PharmD, PhD a , Christophe Van De Wiele MD, PhD i , …
Robotic measurement of arm movements after stroke establishes biomarkers of motor recovery
…, JC Chavez, GS Littman, E Yang, G Byttebier… - Stroke, 2014 - Am Heart Assoc
Background and Purpose— Because robotic devices record the kinematics and kinetics of
human movements with high resolution, we hypothesized that robotic measures collected …
human movements with high resolution, we hypothesized that robotic measures collected …
Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial)
G Donders, G Bellen, G Byttebier, L Verguts… - American journal of …, 2008 - Elsevier
OBJECTIVE: Although many women with recurrent vulvovaginal candidiasis initially benefit
from prophylactic intermittent treatment with antimycotics, most of them experience relapse …
from prophylactic intermittent treatment with antimycotics, most of them experience relapse …
Propofol infusion for induction and maintenance of anaesthesia in patients with end-stage renal disease
B Ickx, ID Cockshott, L Barvais, G Byttebier… - British Journal of …, 1998 - Elsevier
We have investigated the pharmacokinetics and pharmacodynamics of propofol in 11 patients
with end-stage renal disease (ESRD) compared with nine healthy patients during and …
with end-stage renal disease (ESRD) compared with nine healthy patients during and …
[HTML][HTML] Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a …
…, AY Üresin, B Erdogan, L Belmans, G Byttebier… - …, 2023 - thelancet.com
Background Adverse events of special interest (AESIs) were pre-specified to be monitored
for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with …
for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with …
Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
The COVID-19 pandemic has disrupted life throughout the world. Newly developed
vaccines promise relief to people who live in high-income countries, although vaccines and …
vaccines promise relief to people who live in high-income countries, although vaccines and …
Propofol requirements for induction of anesthesia in children of different age groups
…, AEE Meursing, P Axt, GO Byttebier… - Anesthesia & …, 1992 - journals.lww.com
To demonstrate any age-related differences in propofol requirements for induction of
anesthesia, 150 healthy children aged 3–5 yr (n= 50), 6–9 yr (n= 50), and 10–15 yr (n= 50) …
anesthesia, 150 healthy children aged 3–5 yr (n= 50), 6–9 yr (n= 50), and 10–15 yr (n= 50) …
[HTML][HTML] Accurate prediction of clinical stroke scales and improved biomarkers of motor impairment from robotic measurements
DK Agrafiotis, E Yang, GS Littman, G Byttebier… - Plos one, 2021 - journals.plos.org
Objective One of the greatest challenges in clinical trial design is dealing with the subjectivity
and variability introduced by human raters when measuring clinical end-points. We …
and variability introduced by human raters when measuring clinical end-points. We …